- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Aegerion Pharmaceuticals Inc+ Add to Watchlist
AEGR:US67.7000 USD 1.7100 2.46%
As of 20:10:00 ET on 12/05/2013.
Company Profile for Aegerion Pharmaceuticals Inc (AEGR)
Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches small-molecule therapeutics for cardiovascular and metabolic desease. Aegerion's product candidates limit secretion of cholesterol and triglycerides.
Aegerion Pharmaceuticals Inc
Key Executives for Aegerion Pharmaceuticals Inc (AEGR)
|Marc C BeerChairman/CEO||Mark J FitzpatrickChief Financial Officer|
|Mark SumerayChief Medical Officer||Martha J CarterChief Regulatory Officer|
|Craig FraserPresident: US Commercial||Anne Marie CookSenior VP/Secretary/Gen Cnsl|